Patent details

Basic Information

Publication number:

EP2303276

PCT Application Number:

PCT/GB/2009/050496

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP097460984

PCT Publication Number:

WO/2009/138781

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FUMARATE SALT OF 4-(3-CHLORO-2-FLUOROANILINO)-7-METHOXY-6-{Ö1-(N-METHYLCARBAMOYLMETHYL)PIPERIDIN-4-YLÜOXY}QUINAZOLINE

French Title of Invention:

SEL DE FUMARATE DE 4-(3-CHLORO-2-FLUOROANILINO)-7-MÉTHOXY-6-{Ö1-(N-MÉTHYLCARBAMOYLMÉTHYL)PIPÉRIDIN-4-YLÜOXY}QUINAZOLINE

German Title of Invention:

FUMARAT SALZ VON 4-(3-CHLORO-2-FLUOROANILINO)-7-METHOXY-6-{Ö1-(N-METHYLCARBAMOYLMETHYL)PIPERIDIN-4-YLÜOXY}CHINAZOLIN

SPC Number:

Dates

Filing date:

11/05/2009

Grant date:

13/11/2013

EP Publication Date:

13/11/2013

PCT Publication Date:

19/11/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

06/04/2011

EP B1 Publication Date:

13/11/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

11/05/2014

Expiration date:

11/05/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/05/2009

 

 

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Inventor

1

Name:

DOBSON Andrew, Hornby

Address:

United Kingdom (GB)

2

Name:

BOARDMAN Kay, Alison

Address:

United Kingdom (GB)

3

Name:

WHITLOCK Brian

Address:

United Kingdom (GB)

4

Name:

HARD Susan, Elizabeth

Address:

United Kingdom (GB)

Priority

1

Priority Number:

52706 P

Priority Date:

13/05/2008

Priority Country:

United States (US)

2

Priority Number:

110637 P

Priority Date:

03/11/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/517;

Filing date	Document type	Number of pages